Literature DB >> 18604083

Comparison of sub mucosal diathermy and partial resection of Inferior turbinate in the treatment of symptomatic nasal valve blockage.

P Kafle1, M Maharjan, S Shrestha, K C Toran.   

Abstract

OBJECTIVES: to evaluate the efficacy of sub mucosal diathermy (SMD) and partial resection of inferior turbinate (PRIT) in the treatment of symptomatic enlarged inferior turbinates. STUDY
DESIGN: prospective.
METHODS: Forty patients of age group 18 -56 yrs with symptomatic enlarged inferior turbinates had given choices for SMD and PRIT. All the patients had history of failed medical treatment.
RESULTS: Each twenty patients underwent SMD (group I), PRIT (group II), five pt of gr. I had to have anterior nasal packing after surgery for bleeding. Three pt complained of excessive rhinorrhoea for first 2 weeks while 3 pt of Group 1 complained of nasal blockage for 1 week even after intervention. In group 2, 5 pt had to have re-anterior nasal packing after pack removal. Both groups followed up for 6 months. Nine patients were lost in follow up, so excluded from the study. Following 6 months of follow up, 6 patient of gr. I had recurrence with nasal blockage and in gr. II none had recurrence.
CONCLUSION: PRIT is better than SMD in long course; nevertheless it should be reserved for failed SMD, not as a primary option.

Entities:  

Mesh:

Year:  2007        PMID: 18604083

Source DB:  PubMed          Journal:  Kathmandu Univ Med J (KUMJ)        ISSN: 1812-2027


  2 in total

1.  Comparison of Endoscopic Turbinoplasty Versus Conventional Partial Inferior Turbinectomy in Chronic Hypertrophic Rhinitis.

Authors:  M P Kavin Kumar; P Karthikeyan; V Nirmal Coumare
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-03-02

2.  Characteristics of Human Turbinate-Derived Mesenchymal Stem Cells Are Not Affected by Allergic Condition of Donor.

Authors:  Se Hwan Hwang; Hye Kyung Cho; Sang Hi Park; WeonSun Lee; Hee Jin Lee; Dong Chang Lee; Sun Hwa Park; Mi Hyun Lim; Sang A Back; Byeong Gon Yun; Dong Il Sun; Jun Myung Kang; Sung Won Kim
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.